Paul Tudor Jones's PLSE Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 27,791 shares of Pulse Biosciences, Inc. (PLSE) worth $381,570, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in PLSE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Pulse Biosciences (PLSE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pulse Biosciences (PLSE) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +27,791 | New Buy | 27,791 | $13.73 |
Paul Tudor Jones's Pulse Biosciences Investment FAQs
Paul Tudor Jones first purchased Pulse Biosciences, Inc. (PLSE) in Q4 2025, acquiring 27,791 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Pulse Biosciences, Inc. (PLSE) for 1 quarters since Q4 2025.
Paul Tudor Jones's largest addition to Pulse Biosciences, Inc. (PLSE) was in Q4 2025, adding 27,791 shares worth $381,570.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 27,791 shares of Pulse Biosciences, Inc. (PLSE), valued at approximately $381,570.
As of the Q4 2025 filing, Pulse Biosciences, Inc. (PLSE) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Pulse Biosciences, Inc. (PLSE) was 27,791 shares, as reported at the end of Q4 2025.